Literature DB >> 31933857

Protective role of JNK inhibitor SP600125 in sepsis-induced acute lung injury.

Liming Lou1, Dandan Hu1, Suzhen Chen1, Shiqiang Wang1, Yikai Xu1, Yuenuo Huang1, Yali Shi1, Hong Zhang1.   

Abstract

BACKGROUND: Whether the c-Jun N-terminal kinase (JNK) pathway mediates apoptosis in sepsis-induced acute lung injury is not known. Here we investigated the effect of JNK inhibition in a rat model of sepsis-induced lung injury, and assessed expression of JNK and endoplasmic reticulum stress-related proteins.
METHODS: Sepsis was established by cecal ligation and puncture (CLP) in 48 male Sprague-Dawley rats. 32 additional rats underwent sham surgery. 24 CLP rats and 24 sham rats received tail vein injection of 30 mg/kg SP600125. The rest received saline injection. At 6, 12 and 24 h after surgery, blood, bronchoalveolar lavage fluid (BALF) and lung tissue were collected. p-JNK, XBP-1, ATF-4 and CHOP levels of the lung tissue were measured by western blot; and the JNK mRNA levels were measured by qPCR.
RESULTS: The W/D ratios of lungs in the CLP group were significantly higher than those in the sham group, but lower those in the CLP+JNK inhibitor group (P<0.05). TUNEL staining revealed significantly more apoptotic cells in the lungs of the CLP group than the sham group, and in the CLP+JNK inhibitor group the apoptotic index was significantly reduced (P<0.05). XBP-1, ATF-4, CHOP and p-JNK protein levels and JNK mRNA levels were significantly elevated in the CLP group (P<0.05), but significantly ameliorated in the CLP+JNK inhibitor group (P<0.05).
CONCLUSIONS: Inhibition of the JNK signaling pathway mitigates sepsis-induced lung injury. Our results suggest that JNK signaling promotes endoplasmic reticulum stress and thus apoptosis in sepsis-induced lung injury. IJCEP
Copyright © 2019.

Entities:  

Keywords:  Apoptosis; JNK pathway; cecal ligation and puncture; endoplasmic reticulum stress; sepsis

Year:  2019        PMID: 31933857

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  7 in total

Review 1.  Classic Signaling Pathways in Alveolar Injury and Repair Involved in Sepsis-Induced ALI/ARDS: New Research Progress and Prospect.

Authors:  Wenli Li; Duo Li; Yuansen Chen; Halidan Abudou; Haiwang Wang; Jinxia Cai; Yiping Wang; Ziquan Liu; Yanqing Liu; Haojun Fan
Journal:  Dis Markers       Date:  2022-06-18       Impact factor: 3.464

2.  MiR-140 Resensitizes Cisplatin-Resistant NSCLC Cells to Cisplatin Treatment Through the SIRT1/ROS/JNK Pathway.

Authors:  Zhilai Lin; Jianguang Pan; Lei Chen; Xinhang Wang; Yuhua Chen
Journal:  Onco Targets Ther       Date:  2020-08-17       Impact factor: 4.147

3.  Exosomes Derived from ADSCs Attenuate Sepsis-Induced Lung Injury by Delivery of Circ-Fryl and Regulation of the miR-490-3p/SIRT3 Pathway.

Authors:  Weijun Shen; Xuan Zhao; Shitong Li
Journal:  Inflammation       Date:  2021-09-03       Impact factor: 4.092

4.  Narciclasine attenuates sepsis-induced myocardial injury by modulating autophagy.

Authors:  Rong Tang; Liu Jia; Yunlong Li; Junbo Zheng; Pingping Qi
Journal:  Aging (Albany NY)       Date:  2021-05-25       Impact factor: 5.682

5.  Apoptosis signal-regulating kinase 1 (ASK1) inhibition reduces endothelial cytokine production without improving permeability after toll-like receptor 4 (TLR4) challenge.

Authors:  Michael R Miller; Stephen R Koch; Hyehun Choi; Fred S Lamb; Ryan J Stark
Journal:  Transl Res       Date:  2021-04-20       Impact factor: 10.171

Review 6.  Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy.

Authors:  Peter M George; Athol U Wells; R Gisli Jenkins
Journal:  Lancet Respir Med       Date:  2020-05-15       Impact factor: 30.700

7.  Expression of DUSP12 Reduces Lung Vascular Endothelial Cell Damage in a Murine Model of Lipopolysaccharide-Induced Acute Lung Injury via the Apoptosis Signal-Regulating Kinase 1 (ASK1)-Jun N-Terminal Kinase Activation (JNK) Pathway.

Authors:  Zhao Hui; Huang Jie; Guo-Hua Fan
Journal:  Med Sci Monit       Date:  2021-04-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.